 | • レポートコード：MRC2-11QY02546 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：化学・材料 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は解毒剤のグローバル市場について調査・分析したレポートです。種類別（注射、経口）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別解毒剤の競争状況、市場シェア ・世界の解毒剤市場：種類別市場規模 2015年-2020年（注射、経口） ・世界の解毒剤市場：種類別市場規模予測 2021年-2026年（注射、経口） ・世界の解毒剤市場：用途別市場規模 2015年-2020年（病院、クリニック） ・世界の解毒剤市場：用途別市場規模予測 2021年-2026年（病院、クリニック） ・北米の解毒剤市場分析：米国、カナダ ・ヨーロッパの解毒剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの解毒剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の解毒剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの解毒剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Baxter、Fresenius Kabi、Sandoz、Roche、Mylan、Pfizer、Teva、Glaxosmithkline、Merck ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Antidotes Market
The global Antidotes market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Antidotes Scope and Market Size
Antidotes market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antidotes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Antidotes market is segmented into
Injection
Oral
Segment by Application, the Antidotes market is segmented into
Hospital
Clinic
Regional and Country-level Analysis
The Antidotes market is analysed and market size information is provided by regions (countries).
The key regions covered in the Antidotes market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Antidotes Market Share Analysis
Antidotes market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antidotes business, the date to enter into the Antidotes market, Antidotes product introduction, recent developments, etc.
The major vendors covered:
Baxter
Fresenius Kabi
Sandoz
Roche
Mylan
Pfizer
Teva
Glaxosmithkline
Merck
1 Study Coverage
1.1 Antidotes Product Introduction
1.2 Market Segments
1.3 Key Antidotes Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antidotes Market Size Growth Rate by Type
1.4.2 Injection
1.4.3 Oral
1.5 Market by Application
1.5.1 Global Antidotes Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antidotes Market Size, Estimates and Forecasts
2.1.1 Global Antidotes Revenue 2015-2026
2.1.2 Global Antidotes Sales 2015-2026
2.2 Global Antidotes, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Antidotes Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Antidotes Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Antidotes Competitor Landscape by Players
3.1 Antidotes Sales by Manufacturers
3.1.1 Antidotes Sales by Manufacturers (2015-2020)
3.1.2 Antidotes Sales Market Share by Manufacturers (2015-2020)
3.2 Antidotes Revenue by Manufacturers
3.2.1 Antidotes Revenue by Manufacturers (2015-2020)
3.2.2 Antidotes Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antidotes Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antidotes Revenue in 2019
3.2.5 Global Antidotes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Antidotes Price by Manufacturers
3.4 Antidotes Manufacturing Base Distribution, Product Types
3.4.1 Antidotes Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antidotes Product Type
3.4.3 Date of International Manufacturers Enter into Antidotes Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Antidotes Market Size by Type (2015-2020)
4.1.1 Global Antidotes Sales by Type (2015-2020)
4.1.2 Global Antidotes Revenue by Type (2015-2020)
4.1.3 Antidotes Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antidotes Market Size Forecast by Type (2021-2026)
4.2.1 Global Antidotes Sales Forecast by Type (2021-2026)
4.2.2 Global Antidotes Revenue Forecast by Type (2021-2026)
4.2.3 Antidotes Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antidotes Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Antidotes Market Size by Application (2015-2020)
5.1.1 Global Antidotes Sales by Application (2015-2020)
5.1.2 Global Antidotes Revenue by Application (2015-2020)
5.1.3 Antidotes Price by Application (2015-2020)
5.2 Antidotes Market Size Forecast by Application (2021-2026)
5.2.1 Global Antidotes Sales Forecast by Application (2021-2026)
5.2.2 Global Antidotes Revenue Forecast by Application (2021-2026)
5.2.3 Global Antidotes Price Forecast by Application (2021-2026)
6 North America
6.1 North America Antidotes by Country
6.1.1 North America Antidotes Sales by Country
6.1.2 North America Antidotes Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Antidotes Market Facts & Figures by Type
6.3 North America Antidotes Market Facts & Figures by Application
7 Europe
7.1 Europe Antidotes by Country
7.1.1 Europe Antidotes Sales by Country
7.1.2 Europe Antidotes Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antidotes Market Facts & Figures by Type
7.3 Europe Antidotes Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Antidotes by Region
8.1.1 Asia Pacific Antidotes Sales by Region
8.1.2 Asia Pacific Antidotes Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Antidotes Market Facts & Figures by Type
8.3 Asia Pacific Antidotes Market Facts & Figures by Application
9 Latin America
9.1 Latin America Antidotes by Country
9.1.1 Latin America Antidotes Sales by Country
9.1.2 Latin America Antidotes Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Antidotes Market Facts & Figures by Type
9.3 Central & South America Antidotes Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Antidotes by Country
10.1.1 Middle East and Africa Antidotes Sales by Country
10.1.2 Middle East and Africa Antidotes Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Antidotes Market Facts & Figures by Type
10.3 Middle East and Africa Antidotes Market Facts & Figures by Application
11 Company Profiles
11.1 Baxter
11.1.1 Baxter Corporation Information
11.1.2 Baxter Description and Business Overview
11.1.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter Antidotes Products Offered
11.1.5 Baxter Related Developments
11.2 Fresenius Kabi
11.2.1 Fresenius Kabi Corporation Information
11.2.2 Fresenius Kabi Description and Business Overview
11.2.3 Fresenius Kabi Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Fresenius Kabi Antidotes Products Offered
11.2.5 Fresenius Kabi Related Developments
11.3 Sandoz
11.3.1 Sandoz Corporation Information
11.3.2 Sandoz Description and Business Overview
11.3.3 Sandoz Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sandoz Antidotes Products Offered
11.3.5 Sandoz Related Developments
11.4 Roche
11.4.1 Roche Corporation Information
11.4.2 Roche Description and Business Overview
11.4.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Roche Antidotes Products Offered
11.4.5 Roche Related Developments
11.5 Mylan
11.5.1 Mylan Corporation Information
11.5.2 Mylan Description and Business Overview
11.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Mylan Antidotes Products Offered
11.5.5 Mylan Related Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Description and Business Overview
11.6.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pfizer Antidotes Products Offered
11.6.5 Pfizer Related Developments
11.7 Teva
11.7.1 Teva Corporation Information
11.7.2 Teva Description and Business Overview
11.7.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Teva Antidotes Products Offered
11.7.5 Teva Related Developments
11.8 Glaxosmithkline
11.8.1 Glaxosmithkline Corporation Information
11.8.2 Glaxosmithkline Description and Business Overview
11.8.3 Glaxosmithkline Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Glaxosmithkline Antidotes Products Offered
11.8.5 Glaxosmithkline Related Developments
11.9 Merck
11.9.1 Merck Corporation Information
11.9.2 Merck Description and Business Overview
11.9.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Merck Antidotes Products Offered
11.9.5 Merck Related Developments
11.1 Baxter
11.1.1 Baxter Corporation Information
11.1.2 Baxter Description and Business Overview
11.1.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter Antidotes Products Offered
11.1.5 Baxter Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Antidotes Market Estimates and Projections by Region
12.1.1 Global Antidotes Sales Forecast by Regions 2021-2026
12.1.2 Global Antidotes Revenue Forecast by Regions 2021-2026
12.2 North America Antidotes Market Size Forecast (2021-2026)
12.2.1 North America: Antidotes Sales Forecast (2021-2026)
12.2.2 North America: Antidotes Revenue Forecast (2021-2026)
12.2.3 North America: Antidotes Market Size Forecast by Country (2021-2026)
12.3 Europe Antidotes Market Size Forecast (2021-2026)
12.3.1 Europe: Antidotes Sales Forecast (2021-2026)
12.3.2 Europe: Antidotes Revenue Forecast (2021-2026)
12.3.3 Europe: Antidotes Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Antidotes Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Antidotes Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Antidotes Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Antidotes Market Size Forecast by Region (2021-2026)
12.5 Latin America Antidotes Market Size Forecast (2021-2026)
12.5.1 Latin America: Antidotes Sales Forecast (2021-2026)
12.5.2 Latin America: Antidotes Revenue Forecast (2021-2026)
12.5.3 Latin America: Antidotes Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Antidotes Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Antidotes Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Antidotes Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Antidotes Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Antidotes Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antidotes Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Antidotes Market Segments
Table 2. Ranking of Global Top Antidotes Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antidotes Market Size Growth Rate by Type 2020-2026 (Kiloton) & (US$ Million)
Table 4. Major Manufacturers of Injection
Table 5. Major Manufacturers of Oral
Table 6. Global Antidotes Market Size Growth Rate by Application 2020-2026 (Kiloton)
Table 7. Global Antidotes Market Size by Region (Kiloton) & (US$ Million): 2020 VS 2026
Table 8. Global Antidotes Sales by Regions 2015-2020 (Kiloton)
Table 9. Global Antidotes Sales Market Share by Regions (2015-2020)
Table 10. Global Antidotes Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Antidotes Sales by Manufacturers (2015-2020) (Kiloton)
Table 12. Global Antidotes Sales Share by Manufacturers (2015-2020)
Table 13. Global Antidotes Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Antidotes by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antidotes as of 2019)
Table 15. Antidotes Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Antidotes Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Antidotes Price (2015-2020) (US$/Ton)
Table 18. Antidotes Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Antidotes Product Type
Table 20. Date of International Manufacturers Enter into Antidotes Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Antidotes Sales by Type (2015-2020) (Kiloton)
Table 23. Global Antidotes Sales Share by Type (2015-2020)
Table 24. Global Antidotes Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Antidotes Revenue Share by Type (2015-2020)
Table 26. Antidotes Average Selling Price (ASP) by Type 2015-2020 (US$/Ton)
Table 27. Global Antidotes Sales by Application (2015-2020) (Kiloton)
Table 28. Global Antidotes Sales Share by Application (2015-2020)
Table 29. North America Antidotes Sales by Country (2015-2020) (Kiloton)
Table 30. North America Antidotes Sales Market Share by Country (2015-2020)
Table 31. North America Antidotes Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Antidotes Revenue Market Share by Country (2015-2020)
Table 33. North America Antidotes Sales by Type (2015-2020) (Kiloton)
Table 34. North America Antidotes Sales Market Share by Type (2015-2020)
Table 35. North America Antidotes Sales by Application (2015-2020) (Kiloton)
Table 36. North America Antidotes Sales Market Share by Application (2015-2020)
Table 37. Europe Antidotes Sales by Country (2015-2020) (Kiloton)
Table 38. Europe Antidotes Sales Market Share by Country (2015-2020)
Table 39. Europe Antidotes Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Antidotes Revenue Market Share by Country (2015-2020)
Table 41. Europe Antidotes Sales by Type (2015-2020) (Kiloton)
Table 42. Europe Antidotes Sales Market Share by Type (2015-2020)
Table 43. Europe Antidotes Sales by Application (2015-2020) (Kiloton)
Table 44. Europe Antidotes Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Antidotes Sales by Region (2015-2020) (Kiloton)
Table 46. Asia Pacific Antidotes Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Antidotes Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Antidotes Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Antidotes Sales by Type (2015-2020) (Kiloton)
Table 50. Asia Pacific Antidotes Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Antidotes Sales by Application (2015-2020) (Kiloton)
Table 52. Asia Pacific Antidotes Sales Market Share by Application (2015-2020)
Table 53. Latin America Antidotes Sales by Country (2015-2020) (Kiloton)
Table 54. Latin America Antidotes Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Antidotes Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Antidotes Revenue Market Share by Country (2015-2020)
Table 57. Latin America Antidotes Sales by Type (2015-2020) (Kiloton)
Table 58. Latin America Antidotes Sales Market Share by Type (2015-2020)
Table 59. Latin America Antidotes Sales by Application (2015-2020) (Kiloton)
Table 60. Latin America Antidotes Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Antidotes Sales by Country (2015-2020) (Kiloton)
Table 62. Middle East and Africa Antidotes Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Antidotes Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Antidotes Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Antidotes Sales by Type (2015-2020) (Kiloton)
Table 66. Middle East and Africa Antidotes Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Antidotes Sales by Application (2015-2020) (Kiloton)
Table 68. Middle East and Africa Antidotes Sales Market Share by Application (2015-2020)
Table 69. Baxter Corporation Information
Table 70. Baxter Description and Major Businesses
Table 71. Baxter Antidotes Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 72. Baxter Product
Table 73. Baxter Recent Development
Table 74. Fresenius Kabi Corporation Information
Table 75. Fresenius Kabi Description and Major Businesses
Table 76. Fresenius Kabi Antidotes Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 77. Fresenius Kabi Product
Table 78. Fresenius Kabi Recent Development
Table 79. Sandoz Corporation Information
Table 80. Sandoz Description and Major Businesses
Table 81. Sandoz Antidotes Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 82. Sandoz Product
Table 83. Sandoz Recent Development
Table 84. Roche Corporation Information
Table 85. Roche Description and Major Businesses
Table 86. Roche Antidotes Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 87. Roche Product
Table 88. Roche Recent Development
Table 89. Mylan Corporation Information
Table 90. Mylan Description and Major Businesses
Table 91. Mylan Antidotes Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 92. Mylan Product
Table 93. Mylan Recent Development
Table 94. Pfizer Corporation Information
Table 95. Pfizer Description and Major Businesses
Table 96. Pfizer Antidotes Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 97. Pfizer Product
Table 98. Pfizer Recent Development
Table 99. Teva Corporation Information
Table 100. Teva Description and Major Businesses
Table 101. Teva Antidotes Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 102. Teva Product
Table 103. Teva Recent Development
Table 104. Glaxosmithkline Corporation Information
Table 105. Glaxosmithkline Description and Major Businesses
Table 106. Glaxosmithkline Antidotes Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 107. Glaxosmithkline Product
Table 108. Glaxosmithkline Recent Development
Table 109. Merck Corporation Information
Table 110. Merck Description and Major Businesses
Table 111. Merck Antidotes Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 112. Merck Product
Table 113. Merck Recent Development
Table 114. Global Antidotes Sales Forecast by Regions (2021-2026) (Kiloton)
Table 115. Global Antidotes Sales Market Share Forecast by Regions (2021-2026)
Table 116. Global Antidotes Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 117. Global Antidotes Revenue Market Share Forecast by Regions (2021-2026)
Table 118. North America: Antidotes Sales Forecast by Country (2021-2026) (Kiloton)
Table 119. North America: Antidotes Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Europe: Antidotes Sales Forecast by Country (2021-2026) (Kiloton)
Table 121. Europe: Antidotes Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Asia Pacific: Antidotes Sales Forecast by Region (2021-2026) (Kiloton)
Table 123. Asia Pacific: Antidotes Revenue Forecast by Region (2021-2026) (US$ Million)
Table 124. Latin America: Antidotes Sales Forecast by Country (2021-2026) (Kiloton)
Table 125. Latin America: Antidotes Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Middle East and Africa: Antidotes Sales Forecast by Country (2021-2026) (Kiloton)
Table 127. Middle East and Africa: Antidotes Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 129. Key Challenges
Table 130. Market Risks
Table 131. Main Points Interviewed from Key Antidotes Players
Table 132. Antidotes Customers List
Table 133. Antidotes Distributors List
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Antidotes Product Picture
Figure 2. Global Antidotes Sales Market Share by Type in 2020 & 2026
Figure 3. Injection Product Picture
Figure 4. Oral Product Picture
Figure 5. Global Antidotes Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Antidotes Report Years Considered
Figure 9. Global Antidotes Market Size 2015-2026 (US$ Million)
Figure 10. Global Antidotes Sales 2015-2026 (Kiloton)
Figure 11. Global Antidotes Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Antidotes Sales Market Share by Region (2015-2020)
Figure 13. Global Antidotes Sales Market Share by Region in 2019
Figure 14. Global Antidotes Revenue Market Share by Region (2015-2020)
Figure 15. Global Antidotes Revenue Market Share by Region in 2019
Figure 16. Global Antidotes Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Antidotes Revenue in 2019
Figure 18. Antidotes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Antidotes Sales Market Share by Type (2015-2020)
Figure 20. Global Antidotes Sales Market Share by Type in 2019
Figure 21. Global Antidotes Revenue Market Share by Type (2015-2020)
Figure 22. Global Antidotes Revenue Market Share by Type in 2019
Figure 23. Global Antidotes Market Share by Price Range (2015-2020)
Figure 24. Global Antidotes Sales Market Share by Application (2015-2020)
Figure 25. Global Antidotes Sales Market Share by Application in 2019
Figure 26. Global Antidotes Revenue Market Share by Application (2015-2020)
Figure 27. Global Antidotes Revenue Market Share by Application in 2019
Figure 28. North America Antidotes Sales Growth Rate 2015-2020 (Kiloton)
Figure 29. North America Antidotes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Antidotes Sales Market Share by Country in 2019
Figure 31. North America Antidotes Revenue Market Share by Country in 2019
Figure 32. U.S. Antidotes Sales Growth Rate (2015-2020) (Kiloton)
Figure 33. U.S. Antidotes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Antidotes Sales Growth Rate (2015-2020) (Kiloton)
Figure 35. Canada Antidotes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Antidotes Market Share by Type in 2019
Figure 37. North America Antidotes Market Share by Application in 2019
Figure 38. Europe Antidotes Sales Growth Rate 2015-2020 (Kiloton)
Figure 39. Europe Antidotes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Antidotes Sales Market Share by Country in 2019
Figure 41. Europe Antidotes Revenue Market Share by Country in 2019
Figure 42. Germany Antidotes Sales Growth Rate (2015-2020) (Kiloton)
Figure 43. Germany Antidotes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Antidotes Sales Growth Rate (2015-2020) (Kiloton)
Figure 45. France Antidotes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Antidotes Sales Growth Rate (2015-2020) (Kiloton)
Figure 47. U.K. Antidotes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Antidotes Sales Growth Rate (2015-2020) (Kiloton)
Figure 49. Italy Antidotes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Antidotes Sales Growth Rate (2015-2020) (Kiloton)
Figure 51. Russia Antidotes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Antidotes Market Share by Type in 2019
Figure 53. Europe Antidotes Market Share by Application in 2019
Figure 54. Asia Pacific Antidotes Sales Growth Rate 2015-2020 (Kiloton)
Figure 55. Asia Pacific Antidotes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Antidotes Sales Market Share by Region in 2019
Figure 57. Asia Pacific Antidotes Revenue Market Share by Region in 2019
Figure 58. China Antidotes Sales Growth Rate (2015-2020) (Kiloton)
Figure 59. China Antidotes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Antidotes Sales Growth Rate (2015-2020) (Kiloton)
Figure 61. Japan Antidotes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Antidotes Sales Growth Rate (2015-2020) (Kiloton)
Figure 63. South Korea Antidotes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Antidotes Sales Growth Rate (2015-2020) (Kiloton)
Figure 65. India Antidotes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Antidotes Sales Growth Rate (2015-2020) (Kiloton)
Figure 67. Australia Antidotes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Antidotes Sales Growth Rate (2015-2020) (Kiloton)
Figure 69. Taiwan Antidotes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Antidotes Sales Growth Rate (2015-2020) (Kiloton)
Figure 71. Indonesia Antidotes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Antidotes Sales Growth Rate (2015-2020) (Kiloton)
Figure 73. Thailand Antidotes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Antidotes Sales Growth Rate (2015-2020) (Kiloton)
Figure 75. Malaysia Antidotes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Antidotes Sales Growth Rate (2015-2020) (Kiloton)
Figure 77. Philippines Antidotes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Antidotes Sales Growth Rate (2015-2020) (Kiloton)
Figure 79. Vietnam Antidotes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Antidotes Market Share by Type in 2019
Figure 81. Asia Pacific Antidotes Market Share by Application in 2019
Figure 82. Latin America Antidotes Sales Growth Rate 2015-2020 (Kiloton)
Figure 83. Latin America Antidotes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Antidotes Sales Market Share by Country in 2019
Figure 85. Latin America Antidotes Revenue Market Share by Country in 2019
Figure 86. Mexico Antidotes Sales Growth Rate (2015-2020) (Kiloton)
Figure 87. Mexico Antidotes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Antidotes Sales Growth Rate (2015-2020) (Kiloton)
Figure 89. Brazil Antidotes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Antidotes Sales Growth Rate (2015-2020) (Kiloton)
Figure 91. Argentina Antidotes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Antidotes Market Share by Type in 2019
Figure 93. Latin America Antidotes Market Share by Application in 2019
Figure 94. Middle East and Africa Antidotes Sales Growth Rate 2015-2020 (Kiloton)
Figure 95. Middle East and Africa Antidotes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Antidotes Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Antidotes Revenue Market Share by Country in 2019
Figure 98. Turkey Antidotes Sales Growth Rate (2015-2020) (Kiloton)
Figure 99. Turkey Antidotes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Antidotes Sales Growth Rate (2015-2020) (Kiloton)
Figure 101. Saudi Arabia Antidotes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. UAE Antidotes Sales Growth Rate (2015-2020) (Kiloton)
Figure 103. UAE Antidotes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Antidotes Market Share by Type in 2019
Figure 105. Middle East and Africa Antidotes Market Share by Application in 2019
Figure 106. North America Antidotes Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 107. North America Antidotes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Antidotes Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 109. Europe Antidotes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Antidotes Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 111. Asia Pacific Antidotes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Antidotes Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 113. Latin America Antidotes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Antidotes Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 115. Middle East and Africa Antidotes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed
ボツリヌス毒素注射の世界市場（～2026年） Botulinum toxin is a protein that helps stop muscle spasms when it is injected directly into the muscle. Muscle spasms are caused by chemical messages sent to the muscles from nerves. These messages tell the muscles to contract (to tighten up). Botulinum toxin blocks these messages. Market Analysis …- プロポフォール中鎖・長鎖脂肪エマルジョン注射の世界市場（～2026年） Market Analysis and Insights: Global Propofol Medium and Long Chain Fat Emulsion Injection Market The global Propofol Medium and Long Chain Fat Emulsion Injection market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Propofo…
- カルシトニン注射の世界市場（～2026年） Market Analysis and Insights: Global Calcitonin Injection Market The global Calcitonin Injection market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Calcitonin Injection Scope and Market Size Calcitonin Injection market is…
- 粉末射出成形の世界市場（～2026年） Injection Molding is a type of manufacturing technology that can use either metals or ceramics to produce small yet geometrically complex shapes that are widely used in end-user industries like the consumer products and medical devices. The adoption of leading-edge process control and monitoring sys…
- 経口血糖降下薬（OAD）治療の世界市場（～2026年） Diabetic is the condition where the sugar (glucose) level is high in the blood or the production of the insulin is inadequate. Diabetes main type the very first one is Type 1 and the second is Type 2, both the diabetic are most commonly find in the current scenario, apart from this many other diabet…